Clinical Trial Update: Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and serum concentrations of the human monoclonal antibody VRC-HIVMAB075-00-AB (VRC07-523LS) in healthy, HIV-uninfected adults, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• VRC-HIVMAB075-00-AB (VRC07-523LS) (VRC07-523LS)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2022-03-21